Ocular Therapeutix

+$0.37 (+3.69%) Today
$0.00 (0.00%) As of 11:17 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OCUL and other ETFs, options, and stocks.

About OCUL

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC.

CEO
Antony Mattessich
Employees
181
Headquarters
Bedford, Massachusetts
Founded
2006

OCUL Key Statistics

Market Cap
795.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
814.09K
High Today
$10.43
Low Today
$10.01
Open Price
$10.05
Volume
1.21M
52 Week High
$24.30
52 Week Low
$7.50

OCUL News

Simply Wall StSep 16

Despite Lacking Profits Ocular Therapeutix Seems To Be On Top Of Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a

OCUL Earnings

-$1.21
-$0.81
-$0.40
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure